simvastatin has been researched along with Inflammatory Breast Cancer in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brewer, T; Buchholz, TA; Debeb, BG; Hortobágyi, GN; Lacerda, L; Larson, R; Li, L; Liu, D; Masuda, H; Reddy, JP; Ueno, NT; Woodward, WA; Xu, W | 1 |
1 other study(ies) available for simvastatin and Inflammatory Breast Cancer
| Article | Year |
|---|---|
Simvastatin radiosensitizes differentiated and stem-like breast cancer cell lines and is associated with improved local control in inflammatory breast cancer patients treated with postmastectomy radiation.
Topics: Adult; Aged; Cell Differentiation; Chi-Square Distribution; Disease Progression; Disease-Free Survival; Female; Humans; Inflammatory Breast Neoplasms; Kaplan-Meier Estimate; Mastectomy; MCF-7 Cells; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Neoplastic Stem Cells; Proportional Hazards Models; Radiation Tolerance; Radiation-Sensitizing Agents; Radiotherapy, Adjuvant; Retrospective Studies; Risk Factors; Simvastatin; Spheroids, Cellular; Time Factors; Treatment Outcome; Triple Negative Breast Neoplasms; Young Adult | 2014 |